RNA viruses are a major threat to animals and plants. RNA interference (RNAi) and the interferon response provide innate antiviral defense against RNA viruses. Here, we performed a large-scale screen using Caenorhabditis elegans and its natural pathogen the Orsay virus (OrV), and we identified cde-1 as important for antiviral defense. CDE-1 is a homolog of the mammalian TUT4 and TUT7 terminal uridylyltransferases (collectively called TUT4(7)); its catalytic activity is required for its antiviral function. CDE-1 uridylates the 3ʹ end of the OrV RNA genome and promotes its degradation in a manner independent of the RNAi pathway. Likewise, TUT4(7) enzymes uridylate influenza A virus (IAV) mRNAs in mammalian cells. Deletion of TUT4(7) leads to increased IAV mRNA and protein levels. Collectively, these data implicate 3ʹ -terminal uridylation of viral RNAs as a conserved antiviral defense mechanism.
R NA viruses are a major threat to human health and food security. Understanding the fundamental mechanisms by which animals and plants combat viral infections might lead to new therapeutic antiviral approaches. RNAi is an important antiviral pathway in most animals and plants: Dicer recognizes and cleaves the double-stranded viral RNA genome into virus-derived small interfering RNAs (viRNAs), which are loaded into Argonaute proteins, thereby forming the RNA-induced silencing complex, which targets the viral RNA genome 1 . Vertebrates have additionally evolved a cellular signaling-based pathway, the interferon response: after recognition of foreign RNAs (i.e., those that are double-stranded or that bear a 5ʹ -di-or triphosphate), cytosolic receptors of the RIG-I family activate the interferon response, thus resulting in an antiviral state of the cell 2,3 . In the evolutionary arms race between viruses and their hosts, however, animals must have evolved a diverse range of antiviral strategies to avoid relying solely on the RNAi or interferonresponse pathways.
Here, we developed a system for antiviral gene discovery using the nematode C. elegans. We identified 3ʹ -terminal uridylation of viral RNAs as a third antiviral mechanism in animals.
Results
A forward genetic screen identifies new genes required for antiviral defense in C. elegans. We carried out a forward genetic screen to discover antiviral pathways in animals, using C. elegans and its natural intestinal pathogen OrV [4] [5] [6] [7] [8] [9] [10] [11] [12] . OrV is a bipartite positive-strand RNA virus related to the Nodaviridae 4 . As is typical for positivesense RNA viruses, the genomic strand of the OrV is a template for translation. The OrV spreads horizontally in populations of C. elegans; it is taken up orally, infects only intestinal cells and probably exits through defecation 4 . Although C. elegans lacks an interferon pathway, a RIG-I ortholog, DRH-1, acts in viral recognition. DRH-1 forms a viral-recognition complex (ViRC) with the C. elegans Dicer (DCR-1) and the RNA-binding protein RDE-4, thus linking viral recognition to a dedicated antiviral RNAi pathway involving the Argonaute protein RDE-1 (refs 5, 11, 13, 14 ). DRH-1 also induces a transcriptional immune response through a STATdependent signaling pathway 10, 15, 16 (for example, the gene sdz-6, as shown by qRT-PCR in Supplementary Fig. 1a ). However, the antiviral function of the DRH-1-mediated stress response remains to be elucidated. C. elegans also elicits a 'biotic stress response' after OrV infection that is independent of DRH-1 and partially overlaps with the transcriptional responses induced by other types of pathogens, possibly as a result of perturbations in cell homeostasis and/or mechanical integrity 10 (for example, the gene lys-3, encoding an antibacterial enzyme, as shown by qRT-PCR in Supplementary Fig. 1a ). We generated a viral-stress-sensor transgene by placing green fluorescent protein (GFP) under the control of the lys-3 promoter (allele mjIs228; Fig. 1a ). After infection, the level of GFP expression in the intestine mirrored the viral load in wild type and drh-1 and rde-1 mutants ( Supplementary Fig. 1b,c) . We used chemical mutagenesis to screen ~50,000 haploid genomes ( Fig. 1b ) and identified 16 isolates that we termed OrV immune deficient (Ovid; Fig. 1c and Supplementary  Table 1 ). Of 16 ovid mutants, 13 showed increased viral loads (Fig. 1c) . ovid-3, ovid-4, ovid-5, ovid-10 and ovid-12 were found to be compromised in somatic RNAi, as tested by RNAi knockdown of the gene unc-22, which normally results in impaired locomotion (Fig. 1c) ; moreover, ovid-3, ovid-4 and ovid-10 were found to carry new alleles of the RNAi genes mut-16, rde-4 and rrf-1, respectively (Table 1) . To further stratify our Ovid isolates, we assayed DRH-1-pathway activation using the expression of the downstream induced gene sdz-6 as a readout (Fig. 1d ). Only ovid-1 recapitulated the phenotype of drh-1 mutants, and we subsequently demonstrated that ovid-1 defines a new allele of drh-1 (Fig. 1d ). We identified a number of additional candidate genes ( Table 1) . ovid-9 and ovid-11 mutants were defective in neither the canonical RNAi nor the DRH-1 pathway and thus are candidate genes for novel antiviral defense mechanisms.
The terminal uridylyltransferase CDE-1 is required for antiviral defense in C. elegans. Whole-genome resequencing and genetic complementation tests revealed that the causative mutation in ovid-9 was a single-nucleotide nonsense mutation in the cde-1 gene (mj414, Gln910 to stop) ( Fig. 2a and Supplementary Fig. 2 ). cde-1 encodes a catalytically active 3ʹ -terminal RNA uridylyltransferase (TUT), which is a homolog of mammalian TUT4 and TUT7 enzymes [17] [18] [19] (Fig. 2b,c) . The independently derived cde-1 (tm1021)-knockout strain also recapitulated the phenotypes of viral-stress-sensor activation ( Supplementary Fig. 3 ), high viral loads (Fig. 2d ), and horizontal transmission of infection ( Supplementary Fig. 3 ). RNA fluorescence in situ hybridization revealed that viral infection was restricted to the intestine in cde-1 mutants and cde-1; drh-1 double mutants 4,9 ( Supplementary Fig. 4a ). We validated that CDE-1 was present in the intestine using a GFP fusion 18 ( Supplementary Fig. 4b ). To disentangle the functions of CDE-1 in different tissues, we expressed cde-1 exclusively from an intestine-specific vha-6p promoter ( Supplementary Fig. 4c ). Nematodes with intestinal expression of cde-1 became resistant to viral infection ( Supplementary Fig. 4d ) but retained a defect in meiotic chromosome segregation ( Supplementary  Fig. 4e ), which was probably caused by CDE-1 depletion in the germ line 17 . CDE-1 contains a conserved triad of aspartate residues (DDD) in its nucleotidyltransferase domain. Mutation of the corresponding DDD triad to DAD (D1011A) in human Fig. 1 | A forward genetic screen identifies novel antiviral immunity genes. a, Diagram of the lys-3p::gfp viral-stress sensor. UTR, untranslated region. b, Ovid-screen workflow. Transgenic nematodes carrying the viral-stress sensor were mutagenized with ethyl methanesulfonate (EMS), and F 2 progeny were assayed. WT, wild type. c, Top, viral load of strains as indicated, measured by qRT-PCR of OrV RNA1 at 4 d postinfection. Data are represented as mean and s.e.m., n = 4 independent infections. NA, not available. ****P < 0.0001, *** P < 0.001, **P < 0.01, *P < 0.05 by one-tailed Student's t test. Bottom, locomotion defects (paralyzed or twitching) scored after unc-22 RNAi feeding. Data are represented as mean and s.e.m., n = 3 independent RNAi treatments. ****P < 0.0001, **P < 0.01 by two-tailed Student's t test. d, Viral load compared with sdz-6 mRNA levels determined by qRT-PCR. Data are represented as mean and s.e.m., n = 4 independent infections. Samples are as in c. Source data for c and d are available online. TUT4 results in loss of catalytic activity 20 . A cde-1 DADmutant strain ( Fig. 2a ,c) showed similar viral susceptibility to that of the cde-1-null mutants (Fig. 2d ). In summary, we identified CDE-1-mediated 3ʹ terminal uridylation as an antiviral activity in the intestine in C. elegans.
CDE-1 exerts its antiviral function independently of antiviral
RNAi. In eukaryotes, addition of 3ʹ -uridyl tails (U tails) by TUTs is a degradation signal that can engage: (i) the XRN family of exoribonucleases for 5ʹ -to-3ʹ RNA decay; (ii) the 3ʹ -to-5ʹ exoribonuclease DIS3L2; and (iii) the 3ʹ -to-5ʹ exosome complex [21] [22] [23] [24] . We sought to identify the RNAs targeted by CDE-1 in its antiviral role. CDE-1 has been implicated in endogenous RNAi pathways that are restricted to the germ line 17 . Small-RNA sequencing on whole nematodes revealed that small interfering RNAs (siRNAs) are targeted by CDE-1 for 3ʹ uridylation, microRNAs (miRNAs) are occasionally targeted, and piwi-interacting RNAs are not targeted 17 ( Supplementary Fig. 5a ). The role of CDE-1 in small-RNA function remains unclear, because depletion of CDE-1 led to only subtle changes in siRNA and miRNA steady-state levels ( Supplementary Fig. 5b ,c). To understand whether CDE-1 functions through modification of siRNAs in antiviral immunity, we tested cde-1 mutants directly for defects in antiviral RNAi. During an antiviral RNAi response in C. elegans, the ViRC complex recognizes the double-stranded RNA of the replicating viral genome and dices it into sense and antisense ~23-nt-long primary viRNAs, which are loaded into the RDE-1 Argonaute protein 5 (Fig. 3a) . The RNAi response is further amplified by RNA-dependent RNA polymerase (RdRP, RRF-1)-generated 22-nt-long antisense secondary viRNAs, with a 5ʹ -GTP, which are incorporated into secondary Argonaute proteins and aid in silencing viral amplification 5 (Fig. 3a) . Thus, in a nematode with functional antiviral RNAi, a high viral load should correlate with a high level of viRNAs. We measured primary and secondary viRNAs in different genetic backgrounds (Fig. 3b,c ). All the mutants tested (drh-1, rde-1 and cde-1) accumulated higher levels of the virus than did wild type. In drh-1 mutants, primary and secondary viRNAs were less abundant than those in the wild type, despite the higher viral load. In rde-1 mutants, primary viRNAs were abundant, but secondary viR-NAs were depleted, as in the drh-1 mutants. In contrast, the cde-1 mutants accumulated both primary and secondary viRNAs to a level correlating with the high viral load. To determine whether viRNAs might silence viral amplification in cde-1 mutants, we carried out epistasis analysis using null mutants of drh-1, rde-1 and cde-1 (Fig. 3d,e ). Both cde-1; drh-1 and cde-1; rde-1 double mutants showed a higher viral load than did either drh-1 or rde-1 alone. We concluded that CDE-1 does not exert its immune function through the antiviral RNAi pathway. r d e -1 ( n e 2 1 9 )
*** ** ** * Viral RNA replication 1,000 1,000 CDE-1 defines a novel antiviral immunity pathway. In mammals, uridylation is coupled to poly(A)-tail length: TUT4(7) enzymes preferentially uridylate mRNAs with short poly(A) tails (< 25 nt) and facilitate their degradation 25, 26 (Fig. 4a ). We therefore assessed the effect of CDE-1 on endogenous mRNA poly(A)-tail lengths and terminal-nucleotide addition in infected wild-type or cde-1-mutant nematodes using TAIL-seq 25 a major peak of poly(A) tails at ~40 nt and a second peak of poly(A) tails at ~10 nt ( Fig. 4b ; through our method, we were not able to assess transcripts with poly(A) tails > 79 nt). In cde-1 mutants, there was a shift of the major ~40-nt peak to ~36 nt and an increase in transcripts with shorter poly(A) tails (Fig. 4b ). We inferred that CDE-1 might also promote the degradation of transcripts with short poly(A) tails in C. elegans. However, CDE-1 had no global effect on the poly(A)-tail distribution of OrV-induced stress-response genes ( Supplementary Fig. 6a ). In addition, the OrV-induced stress response was stronger in cde-1 mutants than in the wild type after infection ( Supplementary Fig. 6b ), thus reflecting the difference in viral load between these two strains. These findings indicate that CDE-1 is not required for the OrVinduced stress response. Although we cannot formally rule out the possibility that CDE-1 might regulate endogenous targets, the evidence indicated that such regulation is not CDE-1's principal function in antiviral immunity.
Instead, we postulated that the viral RNA genome itself might be uridylated by CDE-1. U tails can be observed on only a small percentage of cellular RNAs, because uridylated RNAs are prone to degradation 26 . To detect degradation intermediates of uridylated OrV RNA, we carried out 3ʹ rapid amplification of cDNA ends (RACE) followed by high-throughput sequencing of the OrV RNAs extracted from C. elegans 2 d postinfection (RACE-seq; Supplementary Fig. 7a ). Mono(U) tails constituted the most abundant fraction of nontemplated nucleotides detected at the 3ʹ ends of both OrV RNA1 and OrV RNA2 ( Fig. 4c-e ). For both RNA1 and 2, U tailing was lost in two independent cde-1-mutant alleles. In contrast, drh-1 and rde-1 mutants showed similar levels of viral RNA U tails to those in the wild type, thus indicating that U tailing is independent of viral load and that CDE-1 is not in limited quantities ( Supplementary Fig. 7b ,c). OrV RNA1 and RNA2 have a terminal uridylyl residue in their genome, such that the addition of an extra nontemplated uridine by CDE-1 forms a UU termination site ( Fig. 4d ), which is a signal for uridylation-dependent RNA decay 21, 23 . The two XRN paralogs in C. elegans (XRN-1 and XRN-2) and the exosome components (for example, DIS-3 and EXOS-2) are essential 28, 29 , and these RNA-degradation pathways normally act redundantly on uridylated RNAs 26 . We therefore subjected C. elegans to a short (24-h) RNAi treatment to effect a partial knockdown of cde-1; the exonuclease gene disl-2 (the C. elegans DIS3L2 homolog); the exosome-component genes exos-2 and dis-3; and the 9 . After it enters the host cell, the virus disassembles in the cytoplasm and exposes its RNA genome. The OrV has a bipartite positive-stand RNA genome that can be directly translated by the cellular machinery. The OrV RNA1 molecule encodes a viral RdRP, and the OrVRNA2 molecule encodes the capsid protein 4 . Virus amplification occurs in the cytoplasm in two steps: (i) the positive-strand genome serves as a template for the synthesis of a negative-strand antigenome by the viral RdRP; (ii) the antigenome in turn serves as a template for further synthesis of genomic RNAs. The C. elegans antiviral RNAi response is initiated by DCR-1-DRH-1-RDE-4 (the ViRC), which recognizes replicating double-stranded viral RNAs and processes them into virus-derived siRNAs (primary viRNAs). Primary viRNAs are loaded into the RDE-1 Argonaute protein and trigger the synthesis of secondary viRNAs by the host RdRP RRF-1, which uses the viral RNA as a template. Secondary viRNAs, loaded into somatic Argonaute proteins (SAGOs), target viral RNAs through base complementarity and potently decrease viral replication 5, 11 . Viral RNAs are also targeted by the terminal uridylyltransferase CDE-1. CDE-1 marks viral RNAs with a 3ʹ -U tail, which recruits 5ʹ -to-3ʹ exonucleases of the XRN family and 3ʹ -to-5ʹ exonucleases of the exosome complex. C. elegans may have additional antiviral pathways; for example, after virus infection, a set of stress-response genes is induced by a STAT signaling pathway that may promote virus clearance (not shown in this model) 15, 16 . Virion cartoon adapted from ref. 12 under a Creative Commons Attribution license (https://creativecommons.org/licenses/by/4.0/). ssRNA, single-stranded RNA. exonuclease gene xrn-2. Treated nematodes, which superficially appeared to have a wild-type phenotype, were infected with OrV for 24 h. The frequency of U tails in OrV RNA2 was measured with RACE-seq (Fig. 4f ), and we found that ~4% of OrV RNA2 was uridylated in nematodes exposed to the empty-vector control RNAi, compared with ~1% under cde-1 knockdown. RNAi treatments against disl-2 did not affect the U-tail frequency. We measured a 1.4-to 1.7-fold increase in U-tail frequency after RNAi knockdown of exos-2, dis-3 and xrn-2, thus suggesting that these factors each contribute to the degradation of uridylated viral RNAs, in accordance with a study showing that DIS3 and the exosome degrade viral RNAs in Drosophila and human cells 30 . We conclude that C. elegans uses uridylation of the OrV as an innate immune defense.
This mechanism acts in parallel to antiviral RNAi in combatting viral infection (Fig. 5 ).
Terminal uridylyltransferases target viral RNAs in mammalian cells. The U-tail modification is conserved in eukaryotes and may affect a broad range of viruses in a variety of hosts 31 . We tested whether U-tailing might affect the replication of IAV, which can infect human and murine cells. The IAV genome consists of eight antisense RNA segments (viral RNAs (vRNAs)) from which the viral RdRP produces (i) the sense complementary RNAs (cRNAs), which serve as templates to produce more vRNAs and (ii) the mRNAs that are 3ʹ polyadenylated and exported to the cytosol for translation into viral proteins 32 (Fig. 6a ). We used RACE-seq to examine the 3ʹ ends of a set of IAV RNAs, at 8 hours postinfection (hpi) in A549 human lung cells. We were not able to detect U tails at the ends of vRNAs or cRNAs. In contrast, viral mRNAs were highly uridylated at their 3ʹ ends, ~77% of the IAV nucleoprotein (NP) mRNA contained a U tail, and a di(U)-tail was the most common type of 3ʹ end (~32%) ( Fig. 6b-e ). The IAV NP mRNA was also uridylated (~40-50%) at 8 hpi in mouse embryonic fibroblasts (MEFs), but uridylation was lost in MEFs deficient in both Tut4 and Tut7 (ref. 25 and Fig. 6f ). Thus, TUT4 (7) uridylates the 3ʹ ends of viral RNAs in mammalian cells. RACE-seq can detect only IAV mRNAs with poly(A) tails < 70 nt; some IAV mRNAs with very long poly(A) tails might be less prone to uridylation. To test the effects of TUT4(7) on IAV, we measured the quantity of NP mRNA by qRT-PCR in infected MEFs ( Supplementary Fig. 8a) . The IAV NP mRNA accumulated more rapidly and to a higher level at the peak in Tut4(7)-knockout MEFs (peak at 8 hpi) compared with wild-type cells (peak at 16 hpi) before decreasing later in infection (24 hpi). In agreement with the difference in mRNA levels, the NP-mRNA-encoded viral NP accumulated more rapidly in Tut4 (7)-knockout than in wild-type MEFs during the first 8 h of infection ( Supplementary Fig. 8b ). Accordingly, more infected cells overall were observed in Tut4 (7)-knockout than in wild-type MEFs (Fig. 6g ). In conclusion, TUT4(7) may act as an early barrier against IAV infection in mammalian cells. Although we cannot rule out the possibility that TUT4 (7) might affect other steps of the IAV viral cycle, such as entry, our data strongly support a model in which TUT4 (7) enzymes act by decreasing the expression of IAV mRNAs during the early stages of IAV infection in MEFs, thus decreasing viral-protein levels and rates of infection. Future studies will need to address the antiviral function of TUT4 (7) in a variety of relevant host-virus models.
Discussion
Previously, we showed that the antiviral RNAi pathway and DRH-1 are central to the innate immune response of C. elegans 5 .
Here, we demonstrated that the terminal uridylyltransferases also play a critical role in antiviral immunity, uridylating viral RNAs (with one or two Us), thereby marking them for degradation. How terminal uridylyltransferases recognize viral RNAs as bona fide targets remains unclear. Receptors of the RIG-I family commonly recognize pathogen-associated patterns at the 5ʹ termini of viral RNAs. In contrast, terminal uridylyltransferases interact with the 3ʹ termini of cytosolic RNAs with no poly(A)-tail or a short poly(A)-tail. Many RNA viruses, such as OrV, lack a poly(A) tail at the 3ʹ terminus of the RNA genome, an architecture that may be a pathogen-associated pattern-recognition feature. We speculate that the IAV mRNAs and a fraction of the OrV RNAs may be vulnerable to TUTs when they are exposed in the cytosol for translation. In conclusion, we found that terminal uridylyltransferases are potent antiviral factors during early stages of RNA virus infection in C. elegans and in mammalian cells. This finding supports a scenario in which eukaryotic mRNA decay pathways originally evolved as intrinsic cellular defenses against pathogens 33, 34 . Vertebrates also benefit from the interferon response and adaptive immune system, serving as potent lines of defense against pathogenic viruses; future studies will therefore need to address the relative importance of antiviral uridylation in whole organisms. Terminal uridylyltransferases are widely conserved in eukaryotes and may potentially target a wide range of RNA viruses 31 . Perhaps as a response to this threat, some viruses have evolved to protect their RNA termini; one such example is the single-stranded RNA viruses of the Flaviviridae family, which have highly structured 3ʹ ends resistant to degradation by cellular exonucleases 35 . Our study illustrates that the 3ʹ termini of viral RNAs are key in the evolutionary arms race between viruses and their hosts.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41594-018-0106-9.
Genetics. Nematodes were grown on agar plates at 20 °C and fed with Escherichia coli strain HB101 (obtained from the Caenorhabditis Genetics Center, University of Minnesota). Standard C. elegans procedures were used for maintenance and genetic crosses 36 . The wild-type strain refers to Bristol N2 unless stated otherwise. All strains used in this study are listed in Supplementary Table 2 .
PCR primers. All PCR primers used in this study are listed in Supplementary  Table 3 .
Viral-filtrate preparation. Viral filtrate was prepared as in ref. 8 . Briefly, JU1580 nematodes were first stably infected with OrV in solid culture and then transferred into a liquid culture containing OP50 bacteria for 7 d. The liquid culture with infected JU1580 was then centrifuged at 16,000g for 30 min, and the supernatant was filtered (0.22-µ m filter) to produce the viral filtrate (stored at -80 °C).
Transgenesis of C. elegans with the lys-3p::GFP viral-stress sensor. The 452bp region upstream of the lys-3 start codon and the first 57 bp of the coding region of lys-3 were used as a promoter and cloned into an entry clone through Multi-Site Gateway cloning (Invitrogen) according to the manufacturer's instructions. The lys-3 donor plasmid was validated by sequencing. Gateway technology was then used to clone the lys-3 fragment in frame with a GFP cDNA. The 3ʹ UTR of the tbb-2 (β -tubulin) gene was used. The lys-3p::GFP:tbb-2-3ʹ UTR plasmid was amplified and purified according to Invitrogen's instructions. The C. elegans microinjection mix contained 5 ng/µ l plasmid lys-3p::GFP:tbb-2-3ʹ UTR; 5 ng/µ l co-injection marker (myo-2::mcherry::unc-54-3ʹ UTR, pharyngeal expression); and 85 ng/µ l 1-kb Invitrogen ladder in 1× injection buffer (20 mM potassium phosphate and 3 mM potassium citrate, pH 7.5). This mix was microinjected into the gonads of rde-1 (ne219) mutants to generate a multicopy extrachromosomal array (allele mjEx547). X-ray integration of the transgene into the C. elegans genome was performed as described previously 37 . Nematodes carrying an integrated transgene (allele mjIs228) were outcrossed three times to generate SX2635 (lacking ne219), referred to as the wild-type viral-stress-sensor strain in this study.
Confocal images of the biostress reporter.
A 2% agar pad was placed on top of a glass slide, and a drop of 10 µ M tetramisol in M9 medium was placed on the agar pad. Nematodes were picked into tetramisol solution. Imaging was performed with an Olympus Upright FV1000 microscope at 10× or 20× magnification, as specified, in FluoView image software (Olympus). Identical microscope settings were used for all images within a figure.
Forward genetic screen for Ovid-screen isolates. Approximately 4,000 viral stress sensor-transgenic nematodes were mutagenized with ethyl methanesulfonate (EMS), as described in refs 36, 38 . Approximately 50,000 F 2 nematodes were infected for 3-4 d, and ~2,000 nematodes showing intestinal GFP were picked individually for retesting. 16 F 2 families showed transmission of viral-stress-sensor activation. Bleach treatment confirmed that OrV removal led to a loss of intestinal GFP signal.
C. elegans infection by the OrV.
Nematodes were infected either for 4 d as asynchronous populations or for 2 d as synchronous populations. Infections of asynchronous populations were performed as in ref. 5 . Briefly, two L4 hermaphrodites were distributed in each 50-mm plate, and, on the next day, 20 µ l of viral filtrate was spread on the plates. Nematodes were harvested (for viral-load measurement) or observed under a Leica M165 FC fluorescence microscope (for scoring of the viral-stress sensor) at 4 d postinfection. This method was typically used for the characterization of the Ovid screen isolates. For the infection of synchronous populations, 200 nematodes at the larval stage L1 were deposited on each 50-mm plate. The next day, L2 nematodes were infected with 20 µ l of viral filtrate homogeneously spread on the plate. Plates were kept right-side up for 24 h. Nematodes were harvested for viral load measurement at 2 d postinfection. This method was used to measure the viral load in cde-1 mutants, as indicated in the figure legends.
RNA measurement by qRT-PCR. Harvested nematodes were washed three times by pelleting and resuspension in M9 solution. Lysis and qRT-PCR were then performed on 5 µ l of nematode pellet with a Power SYBR Green Cells-to-Ct kit (Ambion), as described in ref. 5 . The primers M1835 and M1836 (ref. 13 ), and M4410 and M4411 (ref. 4 ), were used to measure RNA levels of gapdh and OrV gRNA1, respectively.
RNAi-mediated knockdown of unc-22. All the bacterial feeding clones used in this study were a kind gift from the laboratory of J. Ahringer. Bacteria were grown in LB-ampicillin (50 μ g/ml) for 6 h, then seeded onto 50-mm NGM agar plates containing 1 mM IPTG and 25 μ g/ml carbenicillin at a volume of 300 μ l bacterial culture per plate and left to dry at room temperature, protected from the light, for 48 h. Two L4 nematodes were picked onto each RNAi plate, and the young adult progeny were scored for the phenotype of interest after 5 d.
Transgenesis of C. elegans with the CDE-1::GFP fosmid and imaging. The modified fosmid WRM064A_D06, containing a GFP sequence added at the N-terminal end of cde-1, was provided by the TransgeneOme Project (Max Planck Institute of Molecular Cell Biology and Genetics, TransgeneOme Unit; construct 09318202437763223 H08) 39 . The construct was injected into the gonads of N2 nematodes to produce an extrachromosomal array (as described for the biostress reporter), using a myo-3p::mCherry::unc-54-3ʹ UTR construct as a co-injection reporter. Transgenic nematodes (strain SX3123; allele mjEx594) were imaged with an Olympus Upright FV1000 microscope at 10× magnification.
Fluorescence in situ hybridization of the OrV RNA2. Nematodes were harvested in 15 ml of nanopure water and washed three times by pelleting-resuspension in nanopure water. Nematodes were then transferred to 1.5-ml tubes with a glass pipette. 1 ml of fixative solution (4% formaldehyde in 1× PBS) was added, and the samples were incubated on a rotating wheel at room temperature for 45 min. The nematodes were then washed twice by pelleting-resuspension in 1 ml of 1× PBS. Pellets of nematodes was resuspended in 1 ml 70% ethanol and stored at 4 °C. After removal of the ethanol, fixed nematodes were washed once in 1 ml of wash solution (10% formamide, 2× SSC). The nematode pellet was resuspended in 100 µ l of hybridization solution (10% dextran sulfate, 2× SSC and 10% formamide) with 1 µ l 1:50 of the probe v1580-RNA2-TexRed (ACCATGCGAGCATTCTGAACGTCA; a kind gift from M.-A. Félix) and incubated overnight at 30 °C while being protected from light. The next day, the nematodes were washed three times in wash solution by pelleting-resuspension. Eventually, the nematodes were resuspended in 1 ml wash solution with DAPI and incubated at 30 °C for 30 min. The samples were centrifuged, and supernatant was discarded. The nematode pellet was resuspended in 1 ml of 2× SSC solution and stored at 4 °C while being protected from light. The nematodes were then placed on a glass slide in a drop of Vectashield antifade solution (Vector). Imaging was performed on an Olympus Upright FV1000 microscope at 40× magnification, in FluoView image software (Olympus). The same fluorescence settings were used for all images compared.
Transgenesis of C. elegans with the vha-6p::gfp plasmid and viral-load measurement.
The 878-bp region upstream of the vha-6 start codon was used as a promoter and cloned into an entry clone through Multi-Site Gateway cloning (Invitrogen) according to the manufacturer's instructions. The vha-6p donor plasmid was validated by sequencing. Gateway technology was then used to clone the vha-6p upstream of (i) the GFP cDNA or (ii) the full-length cde-1 gene (from ATG to stop with endogenous introns). The 3ʹ UTR of the tbb-2 (β -tubulin) gene was used. The vha-6p::GFP::tbb-2-3ʹ UTR and vha-6p::cde-1::tbb-2-3ʹ UTR plasmids were amplified and purified according to Invitrogen's instructions. The C. elegans microinjection mix comprised 10 ng/µ l plasmid vha-6p::GFP:tbb-2-3ʹ UTR; 10 ng/µ l plasmid vha-6p::cde-1::tbb-2-3ʹ UTR; 5 ng/µ l co-injection marker (myo-2::mcherry::unc-54-3ʹ UTR, pharyngeal expression); and 75 ng/µ l 1-kb Invitrogen ladder in 1× injection buffer (20 mM potassium phosphate and 3 mM potassium citrate, pH 7.5). This mix was microinjected into the gonads of cde-1 (tm1021) mutants to generate a multicopy extrachromosomal array (allele mjEx595). vha-6p-driven GFP expression was observed only in the intestine. 100 nematodes carrying the extrachromosomal array were manually selected for infection (from the L2 larval stage to young adult).
Small-RNA sequencing. Small-RNA libraries were prepared from infected nematodes as previously described 5 . As starting material, we used pellets of nematodes, which were washed three times in M9 solution and resuspended in 1 ml of TriSure (Bioline). RNA extraction was performed according to the manufacturer's instructions. Some populations of siRNAs (including secondary viRNAs) contain a characteristic 5ʹ -triphosphate group that must be replaced by a 5ʹ -monophosphate to allow the 5ʹ ligation step of the library preparation. For this purpose, 1 µ g of RNA was dissolved in 1× 5ʹ -p polyphophatase buffer and 1 µ l of 5ʹ -polyphophatase (Epicentre) and adjusted to a total volume of 20 µ l, incubated for 30 min at 37 °C, subjected to phenol purification and resuspended in 5 µ l nucleasefree water. Entire treated RNA samples were used as starting material for the TruSeq Small RNA kit (Illumina), according to the manufacturer's instructions, to make the '5ʹ -independent libraries' . The '5ʹ dependent libraries' were made through a similar procedure but without polyphophatase treatment, so that only 5ʹ -monophosphate siRNAs (such as primary viRNAs) were able to be cloned. The libraries were sent to the Gurdon Institute sequencing facility for Illumina HiSeq sequencing (SR36). Small-RNA-sequencing data were aligned to the Ensembl WBcel235 release of the C. elegans genome with STAR 40 (v2.5.1b). Briefly, the aligner allows untemplated residues at the ends of an aligned sequence when it is run in local mode. Untemplated 3ʹ sequences were extracted and analyzed with custom Python scripts. Details of the analyses for each small-RNA subtype can be found in the source code. For differential miRNA expression, reads were counted against the miRBase miRNA annotations (miRBase21 hairpins, WBcel235 genome) with featureCounts 41 (v1.5.0-p1). Differential expression analysis was performed on the counts with DESeq2 (ref. 42 ) (v1.10.1).
CRISPR-Cas9 for cde-1 catalytically dead mutant.
A CRISPR-Cas9-mediated mutation of cde-1 was generated as previously described 43 . The guide RNA was from Invitrogen (A-11001) and diluted at 1:1,000 in permeable buffer. Secondary antibodies were incubated for 1 h at room temperature and washed as described before. The stained cells were finally resuspended in 70 µ l P2F. The cell suspension was run on a high-throughput flow cytometer (MACSQuant analyzer 10, Miltenyi Biotec). Uninfected cells were stained in the same manner as infected cells and were used as negative-staining cell populations. Any cells/events that had fluorescence intensity higher than that of all the negative-staining cell populations were gated as virus-infection positive. Data were analyzed in Flowjo (version 10).
Statistics and reproducibility. Statistics were as described in the figure legends.
For Table 1 , ovid-9 data were reproduced in an independent experiment; data on other Ovid isolates were from only the experiment shown. ovid-9 GFP and RNAi scoring was not performed blinded, but the results were reproduced by different authors. For Fig. 1, ovid-9 data were reproduced in an independent experiment; data on other Ovid isolates were from only the experiment shown. Paralyzed nematodes did not move even after the plate was tapped. Twitching nematodes were observed to move but to show distinctive lateral twitching. For Fig. 2 , the data were reproduced in an independent experiment (except for the DAD catalytically dead mutant, for which data were from only the experiment shown). For Fig. 3 , data were reproduced in an independent experiment. For Fig. 4b, data were from only the experiment shown. For Fig. 4d ,e, the data were reproduced in an independent experiment. For Fig. 4f , data were from only the experiment shown. For Fig. 6b ,f, data were from only the experiment shown. For Fig. 6g , the data were reproduced in an independent experiment. For Supplementary Fig. 1a , data were from only the experiment shown, and they corroborated published data, as cited in the text. For Supplementary Fig. 1b , at least two pictures were taken per condition, except for the male, for which the only picture available is shown; all phenotypes (including those in males) were observed multiple times. For Supplementary Fig.  2 , the data were reproduced in an independent experiment but with 28 F 4 families instead of 64 F 8 families. The investigators were not blinded, but the results were reproduced by different authors. For Supplementary Fig. 3 , data were from only the experiment shown. The investigators were not blinded. For Supplementary Fig. 4a , data were from only the experiment shown, and at least two pictures were taken per condition. For Supplementary Fig. 4b , data were from only the experiment shown, and at least two pictures were taken per condition; the results corroborated published findings, as cited in the text. For Supplementary Fig. 4d ,e, data were from only the experiment shown. For Supplementary Fig. 5a -c, data were from only the experiment shown, and the results corroborated published data, as cited in the text. For Supplementary Fig. 6a ,b, data were from only the experiment shown. For Supplementary Fig. 7 , the data were reproduced in an independent experiment. For Supplementary Fig. 8 , the data were reproduced in an independent experiment. 
Data exclusions
Describe any data exclusions. 
Replication
Describe whether the experimental findings were reliably reproduced. Table 1 : ovid-9 data was reproduced in an independent experiment, data on other Ovid isolates only produced in the shown experiment. ovid-9 GFP and RNAi scoring not blinded but reproduced by different authors. Fig. 1 : ovid-9 data was reproduced in an independent experiment, data on other Ovid isolates only produced in the shown experiment. Paralyzed animals were not moving even after tapping the plate. Twitching animals were moving but distinctively twitching laterally. Fig. 2 : reproduced in an independent experiment (except for the DAD catalityc mutant, only produced in the shown experiment). Fig. 3 : reproduced in an independent experiment. Fig. 4b : only produced in the shown experiment. Fig.  4d ,e: reproduced in an independent experiment. Fig. 4f : only produced in the shown experiment. Fig. 6b ,f: only produced in the shown experiment. Figure 6g : reproduced in an independent experiment. Supp. Fig. 1a : only produced in the shown experiment, corroborates published data as cited in the text. Supp. Fig. 1b : at least two pictures taken by condition, except for the male for which the only picture available is shown in the manuscript, all phenotypes (including in males) were observed multiple times. Supp. Fig. 2 : reproduced in an independent experiment but with 28 F4 families instead of 64 F8 families. Not blinded but reproduced by different authors. Supp. Fig. 3 : only produced in the shown experiment. Not blinded. Supp. Fig. 4a : only produced in the shown experiment, at least two pictures per condition. Supp. Fig. 4b : only produced in the shown experiment, at least two pictures per condition, corroborates published data as cited in the text. Supp. Fig. 4d ,e: only produced in the shown experiment. Supp. Fig. 5a -c: only produced in the shown experiment, corroborates published data as cited in the text. Supp. Fig. 6a ,b: only produced in the shown experiment. Supp. Fig. 7 : reproduced in an independent experiment. Supp. Fig. 8 : reproduced in an independent experiment.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
This study is supported by unbiased quantitative measurements (qPCR, NGS, etc.).
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
Investigators were not blind during data collection. This study is however supported by unbiased quantitative measurements (qPCR, NGS, etc.). Critical observations (e.g. GFP scoring) were reproduced by different scientists.
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Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one-or two-sided (note: only common tests should be described solely by name; more complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
Software
Policy information about availability of computer code
Describe the software used to analyze the data in this study.
Excel, R
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for providing algorithms and software for publication provides further information on this topic.
Materials and reagents
Policy information about availability of materials
Materials availability
Indicate whether there are restrictions on availability of unique materials or if these materials are only available for distribution by a for-profit company.
No restriction

Antibodies
Describe the antibodies used and how they were validated for use in the system under study (i.e. assay and species).
Primary anti-influenza A virus nucleoprotein antibodies were purchased from Millipore (MAB8258B | clone A3, biotin-conjugated). FITC conjugated goat antimouse secondary antibodies were purchased from Invitrogen. 
No
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
Description of research animals
Provide details on animals and/or animal-derived materials used in the study.
Invertebrates (C. elegans). Or mammalian lines: All cell lines were tested for negative for mycoplasma. Tut4 (7) CTR and KO MEFs were derived from E13.5 embryos from crosses of Tut4+/fl;Tut7+/fl;R26+/+ and Tut4+/fl;Tut7+/fl;R26ERTcre/ERT-cre mice by standard procedures and immortalized at passage 2 by two consecutive infections with pBabeSV40LT. Cre-mediated deletion to obtain Tut4 (7) null alleles was induced with 600 nM 4-hydroxytamoxifen for three days 25. All mice used in this study were bred and maintained in EMBL Mouse Biology Unit, Monterotondo, and subsequently in the Centre for Regenerative Medicine, Edinburgh. All procedures were done in accordance to the current Italian legislation (Art. 9, 27. Jan 1992, nu116) under license from the Italian health ministry or the UK Home Office regulations, respectively.
Policy information about studies involving human research participants
Description of human research participants
Describe the covariate-relevant population characteristics of the human research participants.
NA
